Peptide record

TPDB92274

CREKA Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity Tumor-homing Peptides modified_plain modified
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92274
CREKA
Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 5-aa modified multi-activity (Antibacterial, Anticancer, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
N-terminal: aminohexanoic acid (Ahx)
Sequence
CREKA
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
5 reviewed residue count
aminohexanoic acid (Ahx) Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell
Homing
Prostate cancer
Prostate-specific membrane antigen (PSMA)

Source & Reference

TumorHoPe2.0
TumorHoPe2
Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer
2021
Nezir A E et al. Amino Acids. 2021 May 53(5):645-652.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
22Rv1, PNT1A
Synthetic
FITC
Additional Detail Fields 2 fields
FITC
22Rv1, PNT1A